Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep Quality in Advanced Glaucoma
NCT06868745Completed
- Sponsor
- Universidade de São Paulo
- Start
- May 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin in sleep disorder (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Pittsburgh Sleep Quality Index at 30 days. Started May 2022; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT06868745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06868745.